Migraine patients offered free access to second CGRP therapy

People with migraine will be able to gain free access to the CGRP drug fremanezumab (Ajovy) from 1 June via a pharma sponsor program. While the first CGRP drug to be listed on the PBS galcanezumab (Emgality) became available on 1 June, fremanezumab injection is still awaiting an announcement of a listing date after receiving ...

Already a member?

Login to keep reading.

© 2021 the limbic